RitonavirDrug CombinationsLopinavirHIV Protease InhibitorsPyrimidinonesSaquinavirDrug InteractionsDrug Therapy, CombinationDrug SynergismAnti-HIV AgentsIndinavirHIV InfectionsArea Under CurveCarbamatesNelfinavirSulfonamidesPyridinesAntineoplastic Combined Chemotherapy ProtocolsBenzoxazinesCytochrome P-450 CYP3ADose-Response Relationship, DrugHIV-1Reverse Transcriptase InhibitorsAntimalarialsOligopeptidesProguanilMethenamineDrug Administration SchedulePlasmaDrug Resistance, ViralAntiretroviral Therapy, Highly ActiveAdenineAntineoplastic AgentsDapsoneRifampinViral LoadCell Line, TumorArtemisininsDrug Screening Assays, AntitumorDrug TherapyOrganophosphonatesAtovaquoneMefloquineTreatment OutcomeMethylthioinosineCyclopentolateDrug AntagonismDrug Dosage CalculationsCross-Over StudiesTropicamideCellophanePyronesOxazinesCD4 Lymphocyte CountAntifungal AgentsSulfamethoxazoleXenograft Model Antitumor AssaysDeoxycytidinePyrimethamineChromatography, High Pressure LiquidHIV ProteaseDrug ResistanceAntitubercular AgentsPharmaceutical PreparationsMicrobial Sensitivity TestsApoptosisZidovudineTreatment FailureInhibitory Concentration 50LamivudineDrug Evaluation, PreclinicalTime FactorsFloxuridineOxidoreductases, N-DemethylatingSulfadoxineCisplatinAdministration, OralPiperazinesDrug-Related Side Effects and Adverse ReactionsPyrazinesMolecular Targeted TherapyNanoconjugatesKetoconazoleP-GlycoproteinBiological AvailabilityAmodiaquinePyrimidinesCell SurvivalAmikacinChloroquineHuman ExperimentationPhentermineRNA, ViralModels, BiologicalPyrrolidinonesFluorouracilSesquiterpenesBoronic AcidsLipodystrophyDoxorubicin